Cargando…

Editorial: Combination Strategies in the Treatment of Melanoma

Detalles Bibliográficos
Autor principal:	Ascierto, Paolo Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801857/ https://www.ncbi.nlm.nih.gov/pubmed/27047798 http://dx.doi.org/10.3389/fonc.2016.00067

Ejemplares similares

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy
por: Trojaniello, Claudia, et al.
Publicado: (2021)

Editorial: Role of pigmentation in melanoma
por: Brożyna, Anna A., et al.
Publicado: (2022)

Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023)

Editorial: Developing combined modality therapy with mitochondria-targeting strategy
por: Teng, Yong
Publicado: (2023)

Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms
por: Lim, Ken-Hong, et al.
Publicado: (2021)

Combined Inhibition of Specific Sirtuins as a Potential Strategy to Inhibit Melanoma Growth
por: Singh, Chandra K., et al.
Publicado: (2020)

What’s new in melanoma? Combination!
por: Ascierto, Paolo A, et al.
Publicado: (2015)

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers
por: Ayoub, Nehad M.
Publicado: (2021)

Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study
por: Del Fiore, Paolo, et al.
Publicado: (2021)

Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
por: Guida, Michele, et al.
Publicado: (2022)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Editorial: Induced cell senescence as a therapeutic strategy for cancer treatment
por: He, Kaiyue, et al.
Publicado: (2022)

Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study
por: Del Fiore, Paolo, et al.
Publicado: (2021)

Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study
por: Del Fiore, Paolo, et al.
Publicado: (2021)

Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study
por: Ascierto, Paolo A., et al.
Publicado: (2023)

Nanoparticle-Based Combination Therapy for Melanoma
por: Chen, Hongbo, et al.
Publicado: (2022)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

Corrigendum: Melanoma in Adolescents and Young Adults (AYA): Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study
por: Del Fiore, Paolo, et al.
Publicado: (2021)

Editorial: Targeting Pancreatic Cancer: Strategies and Hopes
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2022)

Editorial: New strategies to tackle chemoresistance in cancer
por: De Marco, Carmela, et al.
Publicado: (2022)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

What is changing in the adjuvant treatment of melanoma?
por: Ascierto, Paolo A., et al.
Publicado: (2017)

Melanoma: A model for testing new agents in combination therapies
por: Ascierto, Paolo A, et al.
Publicado: (2010)

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience
por: Crispo, Anna, et al.
Publicado: (2021)

Editorial: Fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies
por: Raimondo, Diego, et al.
Publicado: (2023)

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
por: Homan, Morgan, et al.
Publicado: (2022)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Melanoma and Nanotechnology-Based Treatment
por: Zeng, Hong, et al.
Publicado: (2022)

Melanoma: From Research to Treatment
por: Ascierto, Paolo A., et al.
Publicado: (2011)

NF-κB as potential target in the treatment of melanoma
por: Madonna, Gabriele, et al.
Publicado: (2012)

Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer
por: Passardi, Alessandro, et al.
Publicado: (2023)

Editorial: Adverse and Toxic Effects of Childhood Cancer Treatments
por: Ruggiero, Antonio, et al.
Publicado: (2021)

Editorial: EBV-Associated Carcinomas: Presence, Role, and Prevention Strategies
por: Al Moustafa, Ala-Eddin, et al.
Publicado: (2018)

Editorial: Gastrointestinal Tumor Heterogeneity and Related Anti-Cancer Strategies
por: Liao, Rui, et al.
Publicado: (2022)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hrp72c0lgt0817evhgovvc2t4h